Bessemer Group Inc. Purchases 8,366 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Bessemer Group Inc. lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 0.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,798,333 shares of the medical device company's stock after purchasing an additional 8,366 shares during the quarter. Bessemer Group Inc. owned 0.90% of Cooper Companies worth $165,321,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in COO. Captrust Financial Advisors boosted its holdings in Cooper Companies by 9.7% during the third quarter. Captrust Financial Advisors now owns 3,816 shares of the medical device company's stock valued at $421,000 after purchasing an additional 338 shares in the last quarter. HighTower Advisors LLC lifted its position in shares of Cooper Companies by 11.7% during the third quarter. HighTower Advisors LLC now owns 20,506 shares of the medical device company's stock worth $2,261,000 after purchasing an additional 2,155 shares in the last quarter. MML Investors Services LLC boosted its position in Cooper Companies by 1.6% in the 3rd quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company's stock valued at $1,963,000 after buying an additional 280 shares during the last quarter. Nomura Asset Management Co. Ltd. increased its position in Cooper Companies by 8.1% in the third quarter. Nomura Asset Management Co. Ltd. now owns 58,703 shares of the medical device company's stock worth $6,477,000 after purchasing an additional 4,408 shares during the period. Finally, Barclays PLC raised its stake in shares of Cooper Companies by 0.7% during the third quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock worth $51,082,000 after buying an additional 3,070 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

COO has been the subject of a number of recent analyst reports. BNP Paribas raised Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Citigroup cut their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Piper Sandler reissued an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, Robert W. Baird reduced their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Stock Up 0.7 %

COO traded up $0.52 during trading on Monday, reaching $77.98. 673,942 shares of the stock were exchanged, compared to its average volume of 1,393,278. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock's 50 day moving average price is $84.64 and its two-hundred day moving average price is $94.52. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The stock has a market cap of $15.59 billion, a P/E ratio of 39.99, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.